Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
11/16/1999 | US5985279 Humanized antibody against CD18 |
11/16/1999 | US5985278 Anti-αV-integrin monoclonal antibody |
11/16/1999 | US5985277 Useful for diagnosis and treatement of corynebacterium infections and diseases. |
11/16/1999 | US5985276 Destruction of contaminating tumor cells in stem cell transplants using bispecific antibodies |
11/16/1999 | US5985272 Human myeloperoxidase and its therapeutic application |
11/16/1999 | US5985267 Protein toxins active against lepidopteran pests |
11/16/1999 | US5985262 Method of treatment with epithelium derived T-cell factor |
11/16/1999 | CA2217668C Genetic markers for breast and ovarian cancer |
11/16/1999 | CA2088600C Herpes simplex virus vp16 vaccines |
11/16/1999 | CA2072007C Cloning vector for use in lactic acid bacteria and a method for constructing the same |
11/16/1999 | CA2037900C Pokeweed antiviral protein - monoclonal antibody conjugates |
11/16/1999 | CA2012149C Method for producing the hincii restriction endonuclease and methylase |
11/16/1999 | CA2008698C Male flower specific gene sequences |
11/16/1999 | CA2003360C Human vascular permeability factor |
11/16/1999 | CA1340823C Insulin precursors, process for their preparation and process for the preparation of human insulin |
11/13/1999 | CA2248987A1 Novel compounds |
11/12/1999 | CA2270425A1 Amino acid sequence |
11/11/1999 | WO1999057565A2 Methods for diagnosing and evaluating cancer |
11/11/1999 | WO1999057564A1 Method for immobilising and/or crystallising biological macromolecules on carbon nanotubes and uses |
11/11/1999 | WO1999057536A2 Cyclin activation kinase (cak) from human pathogens, and uses related thereto |
11/11/1999 | WO1999057325A2 Enzymes mixture |
11/11/1999 | WO1999057323A1 Chemically modified nucleic acids and methods for coupling nucleic acids to solid support |
11/11/1999 | WO1999057321A1 Method of determining the nucleotide sequence of oligonucleotides and dna molecules |
11/11/1999 | WO1999057320A1 Antisense modulation of cd40 expression |
11/11/1999 | WO1999057319A1 Electronic detection of nucleic acids using monolayers |
11/11/1999 | WO1999057314A1 Electrical integrated nucleic acid isolation, purification and detection |
11/11/1999 | WO1999057313A1 Method and device for isolating nucleic acids |
11/11/1999 | WO1999057312A1 New method for the selection of clones of an expression library involving rearraying |
11/11/1999 | WO1999057311A2 Novel method for the identification of clones conferring a desired biological property from an expression library |
11/11/1999 | WO1999057309A1 Method and probes for the detection of chromosome aberrations |
11/11/1999 | WO1999057308A1 Method for identifying and representing interindividual differences of dna sequences |
11/11/1999 | WO1999057307A1 Method for non-radioactive detection of membrane-bonded nucleic acids and test kit |
11/11/1999 | WO1999057297A1 Viral production process |
11/11/1999 | WO1999057296A1 Partially deleted adenoviral vectors |
11/11/1999 | WO1999057295A1 Recombinant virus expressing foreign dna encoding feline cd80, feline ctla-4 or feline cd86 and uses thereof |
11/11/1999 | WO1999057294A1 Lens transcriptional control elements and methods of use thereof |
11/11/1999 | WO1999057293A1 Human bmp-7 promoter and method for exploring bone-related substance by using the same |
11/11/1999 | WO1999057292A1 Genomic sequences upstream of the coding region of the ifn-alpha2 gene for protein production and delivery |
11/11/1999 | WO1999057291A1 Genomic sequences upstream of the coding region of the g-csf gene for protein production and delivery |
11/11/1999 | WO1999057290A1 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress |
11/11/1999 | WO1999057288A1 Endothelin-converting-enzyme like protein |
11/11/1999 | WO1999057287A2 Beta-glucosidase coding sequences and protein from orpinomyces pc-2 |
11/11/1999 | WO1999057286A1 Putative lactamase proteins from mouse and human |
11/11/1999 | WO1999057285A2 Sucrose phosphate synthase |
11/11/1999 | WO1999057284A2 Attenuated influenza viruses |
11/11/1999 | WO1999057283A1 Preparation of human papillomavirus e1 having helicase activity and method therefor |
11/11/1999 | WO1999057282A2 Pesticidal toxins and nucleotide sequences which encode these toxins |
11/11/1999 | WO1999057281A2 Peptide antibiotics which inhibit the growth of pneumococci, abc transporter and two-component signal transduction system proteins from streptococcus pneumoniae, and methods using the same |
11/11/1999 | WO1999057280A2 Neisseria meningitidis antigens and compositions |
11/11/1999 | WO1999057279A1 Plasmid for gene expression in pichia ciferrii and transformation method using the same |
11/11/1999 | WO1999057278A2 IMMUNIZATION AGAINST AND TREATMENT FOR INFECTION BY $i(H.PYLORI) |
11/11/1999 | WO1999057277A2 Basb019 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses |
11/11/1999 | WO1999057276A1 Multifunctional adhesin proteins and their display in microbial cells |
11/11/1999 | WO1999057275A1 Introduction of naked dna or rna encoding non-human vertebrate peptide hormones or cytokines into a non-human vertebrate |
11/11/1999 | WO1999057274A1 Human protease associated proteins |
11/11/1999 | WO1999057273A2 Cytoplasmic antiproteinase-3 coding sequence in gene therapy |
11/11/1999 | WO1999057272A1 Peptide inhibitors of hiv replication |
11/11/1999 | WO1999057271A2 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides |
11/11/1999 | WO1999057270A2 Human receptor molecules |
11/11/1999 | WO1999057269A1 Human hrpi |
11/11/1999 | WO1999057268A1 Chimeric receptors |
11/11/1999 | WO1999057267A2 Human epididymal glytathione peroxidase |
11/11/1999 | WO1999057266A2 Immunosuppression by blocking t cell co-stimulation signal 2 (b7/cd28 interaction) |
11/11/1999 | WO1999057265A1 Chimeric decoy rnas having synergistic anti-hiv activity |
11/11/1999 | WO1999057264A1 Method for prolonged storage of dna molecules and packaging implementing said method |
11/11/1999 | WO1999057263A1 Modifying the expression of the fsh beta gene by homologous recombination |
11/11/1999 | WO1999057261A2 Human bmp-2 promoter and method for exploring bone-related substance by using the same |
11/11/1999 | WO1999057255A1 Novel rhamnogalacturonan hydrolases |
11/11/1999 | WO1999057253A2 Crystallizable jnk complexes |
11/11/1999 | WO1999057249A1 Nicotianamine synthase and gene encoding the same |
11/11/1999 | WO1999057247A1 Nucleic acids that control seed and fruit development in plants |
11/11/1999 | WO1999057245A1 Methods of screening for agonists and antagonists of the interaction between the human kiaa0001 receptor and ligands thereof |
11/11/1999 | WO1999057244A1 Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying same |
11/11/1999 | WO1999057241A2 Myelin basic protein peptides and uses thereof |
11/11/1999 | WO1999057157A1 Laundry detergent and/or fabric care compositions comprising a modified antimicrobial protein |
11/11/1999 | WO1999057155A1 Laundry detergent and/or fabric care compositions comprising a modified antimicrobial protein |
11/11/1999 | WO1999057153A1 Heparanase specific molecular probes and their use in research and medical applications |
11/11/1999 | WO1999057151A2 FAP α-SPECIFIC ANTIBODY WITH IMPROVED PRODUCIBILITY |
11/11/1999 | WO1999057150A2 Multivalent antibody constructs |
11/11/1999 | WO1999057149A2 Compounds and methods for modulating nonclassical cadherin-mediated functions |
11/11/1999 | WO1999057148A1 Melanocortin 1 receptor selective compounds |
11/11/1999 | WO1999057147A1 Human thrombopoietin mutants |
11/11/1999 | WO1999057145A2 Human bmp-4 promoter and method for exploring bone-related substance by using the same |
11/11/1999 | WO1999057144A2 Human transcriptional regulator molecules |
11/11/1999 | WO1999057143A1 Transcriptional regulatory factor |
11/11/1999 | WO1999057140A2 Growth-associated protease inhibitor heavy chain precursor |
11/11/1999 | WO1999057138A1 Compositions comprising a peptide inhibitor of nuclear protein translocation and an immunosuppresssant and methods of use thereof |
11/11/1999 | WO1999057133A2 Inhibitors of nf-kb activation |
11/11/1999 | WO1999057132A1 Secreted proteins and polynucleotides encoding them |
11/11/1999 | WO1999057131A1 Method of treating bladder and lower urinary tract syndromes |
11/11/1999 | WO1999057129A1 Pathogeniv tau mutations |
11/11/1999 | WO1999057128A1 Optimization of pest resistance genes using dna shuffling |
11/11/1999 | WO1999056865A1 Device and method for producing a system of chain molecules on a support material |
11/11/1999 | WO1999056784A2 Inprovements in gene therapy using compositions comprising a polynucleotide and a nuclease inhibitor or interleukin-10 |
11/11/1999 | WO1999056778A1 The cytokine family member, 2-19 |
11/11/1999 | WO1999056775A1 Use of interleukin-18 as vaccine adjuvant |
11/11/1999 | WO1999056774A1 Viral chimeras comprised of caev and hiv-1 genetic elements |
11/11/1999 | WO1999056771A2 Methods of raising animals for meat production |
11/11/1999 | WO1999056769A2 Inhibition of helicobacter pylori proliferation |
11/11/1999 | WO1999056759A1 Bone marrow cells as a source of neurons for brain and spinal cord repair |